Device safety

Allurion Gastric Balloon: Updated safety information due to the risks of gastric outlet obstruction, small bowel obstruction and gastric perforation (DSI/2026/004)

Issued 27 May 2026 · DSI/2026/004

Read and act on the official notice on GOV.UK

The MHRA's summary

In rare instances, the Allurion Gastric Balloon has not transited through the stomach or bowel as intended, leading to complications such as gastric outlet obstruction, small bowel obstruction and gastric perforation.

MHRA's audience tags: Anaesthetics, Critical care, Emergency medicine, General practice, General surgery, Gi hepatology pancreatic disorders, Radiology

Pharmshark is not an official alerting route. Make sure your pharmacy receives alerts directly from the MHRA and through your organisation, and always act on the official GOV.UK notice.

Source: the MHRA on GOV.UK. Contains public sector information licensed under the Open Government Licence v3.0. Pharmshark is not affiliated with or endorsed by the MHRA.